Steroid dexamethasone reduces deaths among patients with severe COVID-19 - trial shows

Reuters India Tuesday, 16 June 2020 ()
Giving low doses of the generic steroid drug dexamethasone to patients admitted to hospital with COVID-19 reduced death rates by around a third among those with the most severe cases of infection, trial data showed on Tuesday.
0
shares
 
Video credit: CBS2 LA - Published
News video: Cheap Steroid Successful In Reducing Death Risk Among Severely Ill Coronavirus Patients, Clinical Trial Finds

Cheap Steroid Successful In Reducing Death Risk Among Severely Ill Coronavirus Patients, Clinical Trial Finds 02:39

 The steroid dexamethasone has been found to reduce the risk of death in seriously ill coronavirus patients by about a third, according to clinical trial results hailed on Tuesday as a "major breakthrough." The drug did not appear to help less severely ill patients.